SCHEMBL23325192

SCHEMBL23325192

N#CC1(c2ccccc2OC(F)(F)F)CCNCC1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
BDKRB1 P46663 1/20 0.42
SIGMAR1 Q99720 1/20 0.39
SLC6A2 P23975 6/20 0.36
SLC6A4 P31645 6/20 0.36
KCNH2 Q12809 4/20 0.36
CYP2D6 P10635 4/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
P2RY1 P47900 1/20 0.35
SLC6A3 Q01959 2/20 0.35
HDAC6 Q9UBN7 1/20 0.34
TACR1 P25103 1/20 0.34
HTR2C P28335 1/20 0.33
HTR2B P41595 1/20 0.33
BACE1 P56817 1/20 0.32
DDB1 Q16531 2/20 0.32
CRBN Q96SW2 2/20 0.32
USP2 O75604 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29531771 1.00 BDKRB1 (0.42) BDKRB1SIGMAR1SLC6A2SLC6A4KCNH2
SCHEMBL624675 0.87 BDKRB1 (0.44) BDKRB1MEN1KMT2AP2RY1SLC6A3
SCHEMBL8188193 0.85 BDKRB1 (0.43) BDKRB1SLC6A2SLC6A4MEN1KMT2A
SCHEMBL2288483 0.82 BDKRB1 (0.43) BDKRB1MEN1KMT2AHDAC6BACE1
SCHEMBL615237 0.81 SIGMAR1 (0.60) SIGMAR1CYP2D6KMT2AHTR2CUSP2
Hydrochloric Acid SCHEMBL1266534 0.79 SIGMAR1 (0.59) SIGMAR1CYP2D6KMT2AHTR2CUSP2
Bromide SCHEMBL2276225 0.79 SIGMAR1 (0.59) SIGMAR1CYP2D6KMT2AHTR2CUSP2
SCHEMBL11484577 0.78 SLC6A2 (0.47) SIGMAR1SLC6A2SLC6A4SLC6A3
SCHEMBL5726943 0.78 ADRA1D (0.41) BDKRB1SLC6A2SLC6A4TACR1HTR2C
SCHEMBL615034 0.77 OPRM1 (0.37) BDKRB1SIGMAR1SLC6A2SLC6A4HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021083328-A1 POLYSUBSTITUTED ISOINDOLINE COMPOUNDS, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF 中国科学院上海药物研究所 2021-05-06 WO disclosed